Oorja Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 40.00 K
- Revenue Growth 21.41%
- Profit Growth 110.33%
- Ebitda 254.29%
- Net Worth 6.47%
- Total Assets -13.64%
About Oorja Life Sciences
Oorja Life Sciences Private Limited (OLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 September 2010 and has a history of 14 years and four months. Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Consumer Goods Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹40,000.00.
Kapil Dube, Rohit Jain, Pradeep Dube, and One other member serve as directors at the Company.
Company Details
-
Location
Indore, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24233MP2010PTC024363
-
Company No.
024363
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Sep 2010
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Oorja Life Sciences?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kapil Dube
|
Director | 20-Sep-2010 | Current |
|
Rohit Jain
|
Director | 20-Sep-2010 | Current |
|
Pradeep Dube
|
Director | 19-Dec-2017 | Current |
|
Saurabh Kumar
|
Director | 27-Jul-2019 | Current |
Financial Performance of Oorja Life Sciences.
Oorja Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 21.41% increase. The company also saw a substantial improvement in profitability, with a 110.33% increase in profit. The company's net worth moved up by a moderate rise of 6.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oorja Life Sciences?
In 2020, Oorja Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.04 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Sep 2016 | State Bank Of India | ₹0.04 M | Open |
How Many Employees Work at Oorja Life Sciences?
Unlock and access historical data on people associated with Oorja Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oorja Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oorja Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
